Cover Image

Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action

Saad Shaaban, Amr Negm, Elsayed E. Ibrahim, Ahmed A. Elrazak
  • Saad Shaaban
    Department of Chemistry, Mansoura University, Egypt
  • Elsayed E. Ibrahim
    Department of Zoology, Mansoura University, Egypt
  • Ahmed A. Elrazak
    Department of Botany, Mansoura University, Egypt


Hepatocellular carcinoma (HCC) is a dreaded malignancy that every year causes half a million deaths worldwide. Being an aggressive cancer, its incidence exceeds 700,000 new cases per year worldwide with a median survival of 6-8 months. Despite advances in prognosis and early detection, effective HCC chemoprevention or treatment strategies are still lacking, therefore its dismal survival rate remains largely unchanged. This review will characterize currently available chemotherapeutic drugs used in the treatment of HCC. The respective mode(s) of action, side effects and recommendations will be also described for each drug.


liver cancer, hepatocellular carcinoma, molecular therapies, chemoresistance.

Full Text:

Submitted: 2014-02-04 19:53:28
Published: 2014-05-28 15:23:40
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Copyright (c) 2014 Saad Shaaban, Amr Negm, Elsayed E. Ibrahim, Ahmed A. Elrazak

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185